-
EP1725233
European procedure
Extract from the Register of European Patents
EP About this file: EP1725233
| EP1725233 - PHARMACEUTICAL COMPOSITION COMPRISING SNS-595 AND USES THEREOF [Right-click to bookmark this link] | |||
| Former [2006/48] | SNS-595 AND METHODS OF USING THE SAME | ||
| [2010/45] | Status | No opposition filed within time limit Status updated on 11.11.2011 Database last updated on 11.04.2026 | Most recent event Tooltip | 14.02.2020 | Change - lapse in a contracting state | published on 18.03.2020 [2020/12] | Applicant(s) | For all designated states Sunesis Pharmaceuticals, Inc. 395 Oyster Point Blvd., Suite 400 South San Francisco, CA 94080 / US | For all designated states Dainippon Sumitomo Pharma Co., Ltd. 6-8, Dosho-machi 2-chome Chuo-ku Osaka-shi Osaka 541-8524 / JP | [2011/15] |
| Former [2009/13] | For all designated states Sunesis Pharmaceuticals, Inc. 395 Oyster Point Blvd., Suite 400 South San Francisco, CA 94080 / US | ||
| For all designated states DainipponSumitomo Pharma Co., Ltd 5-51 Ebie 1-chome Fukushima-ku Osaka-shi Osaka 553-0001 / JP | |||
| Former [2006/50] | For all designated states Sunesis Pharmaceuticals, Inc. 341 Oyster Point Boulevard South San Francisco, CA 94080 / US | ||
| For all designated states DainipponSumitomo Pharma Co., Ltd 5-51 Ebie 1-chome Fukushima-ku Osaka-shi Osaka 553-0001 / JP | |||
| Former [2006/48] | For all designated states Sunesis Pharmaceuticals, Inc. 341 Oyster Point Boulevard South San Francisco, CA 94080 / US | Inventor(s) | 01 /
HIGAKI, Masaru 5-51,Ebie 1-chome,Fukushima-ku Osaka-shi, Osaka / JP | 02 /
NAKAO Satoshi 5-51, Ebie 1-chome, Fukushima-ku Osaka-shi, Osaka, 553-0001 / JP | [2010/50] |
| Former [2007/09] | 01 /
ADELMAN, Daniel, C. 23 Woodleaf Avenue Redwood City, CA 94061 / US | ||
| 02 /
SILVERMAN, Jeffrey, A. 1416 Columbus Avenue Burlingame, CA 94010 / US | |||
| 03 /
HIGAKI, Masaru 5-51,Ebie 1-chome,Fukushima-ku Osaka-shi, Osaka / JP | |||
| Former [2007/06] | 01 /
ADELMAN, Daniel, C. 23 Woodleaf Avenue Redwood City, CA 94061 / US | ||
| 02 /
SILVERMAN, Jeffrey, A. 1416 Columbus Avenue Burlingame, CA 94010 / US | |||
| 03 /
HIGASKI, Masaru 5-51,Ebie 1-chome,Fukushima-ku Osaka-shi, Osaka / JP | |||
| Former [2006/48] | 01 /
ADELMAN, Daniel, C. 23 Woodleaf Avenue Redwood City, CA 94061 / US | ||
| 02 /
SILVERMAN, Jeffrey, A. 1416 Columbus Avenue Burlingame, CA 94010 / US | Representative(s) | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Gewürzmühlstraße 11 80538 München / DE | [N/P] |
| Former [2006/48] | Jones Day Rechtsanwälte, Attorneys-at-Law, Patentanwälte Prinzregentenstrasse 11 80538 München / DE | Application number, filing date | 05731600.2 | 14.03.2005 | [2006/48] | WO2005US08346 | Priority number, date | US20040553578P | 15.03.2004 Original published format: US 553578 P | [2006/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2005089757 | Date: | 29.09.2005 | Language: | EN | [2005/39] | Type: | A1 Application with search report | No.: | EP1725233 | Date: | 29.11.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 29.09.2005 takes the place of the publication of the European patent application. | [2006/48] | Type: | B1 Patent specification | No.: | EP1725233 | Date: | 05.01.2011 | Language: | EN | [2011/01] | Search report(s) | International search report - published on: | US | 29.09.2005 | (Supplementary) European search report - dispatched on: | EP | 21.04.2009 | Classification | IPC: | A61K31/44, A61P35/00, A61P35/02, A61K38/18, A61K9/00 | [2009/21] | CPC: |
A61K9/0019 (EP,US);
A61K31/44 (EP,KR,NO,US);
A61K31/4375 (EP,CN,NO,US);
A61K31/282 (EP,US);
A61K31/337 (EP,US);
A61K31/395 (EP,US);
A61K31/407 (EP,US);
A61K31/4745 (EP,US);
A61K31/513 (EP,US);
A61K31/519 (EP,US);
A61K31/52 (EP,US);
A61K31/555 (EP,US);
A61K31/585 (EP,US);
A61K31/704 (EP,US);
A61K31/7048 (EP,US);
A61K31/7068 (EP,US);
A61K38/15 (EP,US);
A61K38/1816 (EP,US);
A61K41/00 (EP,US);
A61K45/06 (EP,US);
A61K47/12 (US);
A61P1/08 (EP);
A61P13/08 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P43/00 (EP);
A61P7/06 (EP);
C07D471/04 (EP,US);
F24S10/70 (EP,US);
F24S50/40 (EP,US);
F24S80/60 (EP,US);
H02S40/38 (EP,US);
H02S40/44 (US);
H10F77/488 (EP,US);
H10F77/63 (US);
Y02E10/40 (US);
Y02E10/44 (EP);
Y02E10/52 (EP,US);
Y02E10/60 (EP);
Y02E70/30 (EP)
(-)
| C-Set: |
A61K31/44, A61K2300/00 (EP,US);
A61K31/4745, A61K2300/00 (US,EP);
A61K31/555, A61K2300/00 (US,EP);
A61K41/00, A61K2300/00 (US,EP) |
| Former IPC [2006/48] | A61K31/44 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/48] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | LV | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND SNS-595 UND DEREN VERWENDUNGEN | [2010/45] | English: | PHARMACEUTICAL COMPOSITION COMPRISING SNS-595 AND USES THEREOF | [2010/45] | French: | COMPOSITION PHARMACEUTIQUE COMPRENANT DU SNS-595 ET ET LEURS UTILISATIONS | [2010/45] |
| Former [2006/48] | SNS-595 UND ANWENDUNGSVERFAHREN | ||
| Former [2006/48] | SNS-595 AND METHODS OF USING THE SAME | ||
| Former [2006/48] | SNS-595 ET METHODES D'UTILISATION DE CE DERNIER | Entry into regional phase | 18.09.2006 | National basic fee paid | 18.09.2006 | Search fee paid | 18.09.2006 | Designation fee(s) paid | 18.09.2006 | Examination fee paid | Examination procedure | 18.09.2006 | Examination requested [2006/48] | 06.07.2009 | Amendment by applicant (claims and/or description) | 04.08.2009 | Despatch of a communication from the examining division (Time limit: M04) | 02.12.2009 | Reply to a communication from the examining division | 12.07.2010 | Cancellation of oral proceeding that was planned for 20.07.2010 | 16.07.2010 | Despatch of a communication from the examining division (Time limit: M02) | 20.07.2010 | Date of oral proceedings (cancelled) | 10.09.2010 | Reply to a communication from the examining division | 22.10.2010 | Communication of intention to grant the patent | 26.11.2010 | Fee for grant paid | 26.11.2010 | Fee for publishing/printing paid | Divisional application(s) | EP10177951.0 / EP2295056 | EP15202939.3 / EP3053579 | Opposition(s) | 06.10.2011 | No opposition filed within time limit [2011/50] | Fees paid | Renewal fee | 28.03.2007 | Renewal fee patent year 03 | 27.03.2008 | Renewal fee patent year 04 | 26.03.2009 | Renewal fee patent year 05 | 25.03.2010 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2016/36] | IS | 05.01.2011 | |
| Former [2016/34] | deleted | ||
| Former [2013/33] | IS | 05.01.2011 | Documents cited: | Search | [XY] US5817669 (TOMITA KYOJI et al.) [X] 1-42 * column 45; example D1; claim 15; tables 1,2; compound 1 *[Y] 9,11,22-25,27-42 | [Y] US2003216316 (HARAN-GHERA NECHAMA et al.) [Y] 9,11,22,25 * abstract * | [Y] US5078996 (CONLON III PAUL J et al.) [Y] 9,11,22-24 * abstract * | [Y] WO0174395 (BAXTER INT et al.) [Y] 27-42 * the whole document * | [X] TSUZUKI ET AL: "Synthesis and Structure-Activity Relationships of Novel 7-Substituted 1,4-Dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic Acids as Antitumor Agents. Part 2", 1 January 2004, JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON., US, PAGE(S) 2097 - 2109, ISSN: 0022-2623, XP002352356 [X] 1-8,12-21 * the whole document * DOI: http://dx.doi.org/10.1021/jm0304966 | International search | [Y] DATABASE CAPLUS [online] TOMITA K. ET AL: "Synthesis and antitumor activity of novel 7-substituted 1,4-dihydro-4-oxo-1-2(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids.", XP003022269, accession no. stn Database accession no. (1999:92763) [Y] | [Y] BK ABSTRACTS, 21TH ACS NAT MTG., 21 March 1999 (1999-03-21) - 25 March 1999 (1999-03-25) | [Y] DATABASE BIOSIS [online] KASHIMOTO S. ET AL: "Antitumor activity of a novel quinolone analog AG-7352 in human xenografr models of leukemia or drug-resistant tumors and in an experimental metastatic tumor model.", XP003022270, Database accession no. PREV200100366681 [Y] | [Y] PROC.AM ASSOC CAN RES AN MTG., vol. 42, no. 102, March 2001 (2001-03-01) | [Y] DATABASE MEDLINE [online] HERMAN T. ET AL: "Nabilone: a potent antiemetic cannabinol with minimal euphoria.", XP003022271, accession no. stn Database accession no. (1978104303) [Y] | [Y] BIOMEDICINE., vol. 27, no. 9-10, December 1977 (1977-12-01), pages 331 - 334 | [Y] DATABASE MEDLINE [online] ALLEN J. ET AL: "Complications of chemotherapy in patients with brain and spinal cord tumors.", XP003022272, accession no. stn Database accession no. (1992345081) [Y] | [Y] PED NEUROSURG., vol. 17, no. 4, 1991 - 1992, pages 218 - 224 | [Y] DATABASE MEDLINE [online] RYFFEL B. ET AL: "Safety of human recombinant proteins.", XP003022273, accession no. stn Database accession no. (1997254190) [Y] | [Y] BIOMED. ENVIRON SCI., vol. 10, no. 1, March 1997 (1997-03-01), pages 65 - 72 | [Y] DATABASE BIOSIS [online] GLASPY J. ET AL: "A dose-finding and safety study of novel erythropoiesis stimulating protein(NESP) for the treatment on anaemia in patients receiving multicycle chemotherapy.", XP003022274, Database accession no. (2001:299057) [Y] | [Y] BR. J CANC., vol. 84, no. 1, April 2001 (2001-04-01), pages 17 - 23 |